Related Experiment Video
Updated: Jul 4, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Infective endocarditis 2006: indications for surgery
Insights
Infective endocarditis remains a significant challenge, with high complication and mortality risks. Advances in surgery offer improved outcomes for heart failure and resistant infections, but more data is needed.
Area of Science:
- Cardiology
- Infectious Diseases
- Cardiac Surgery
Background:
- Infective endocarditis (IE) poses a persistent clinical challenge with high complication and mortality rates.
- Patient demographics and evolving microbial resistance patterns contribute to the disease's severity.
- Current treatment strategies face limitations due to a lack of robust clinical trial data.
Purpose of the Study:
- To review the current indications and evolving role of surgery in managing infective endocarditis.
- To highlight the challenges in treatment recommendations due to limited prospective data.
- To emphasize the importance of ongoing research and registry efforts.
Main Methods:
- Review of existing literature on infective endocarditis and surgical management.
- Analysis of current clinical practice guidelines and challenges.
- Discussion of the impact of patient factors and evolving microbiology.
Main Results:
- Surgery is primarily indicated for acute heart failure, intracardiac abscess, and antibiotic-resistant infections in IE.
- Surgical intervention for preventing systemic embolization in patients with large vegetations is an area of evolving practice.
- High-volume centers report improving surgical outcomes with advancements in techniques and perioperative care.
Conclusions:
- Despite advances, infective endocarditis continues to present significant risks.
- Surgical management is crucial for specific complications, and its role in preventing embolization is expanding.
- Further multi-center registry data is essential to strengthen treatment recommendations in valvular heart disease.
Abstract:
Infective endocarditis has challenged clinicians for centuries. Despite recent advances in diagnosis and therapy, the risks of major complications and death in many clinical situations remain unacceptably high, related in part to patient demographics and the changing microbiology of the disease. Surgery in the acute phase is indicated chiefly for the treatment of heart failure, the eradication of intra-cardiac abscess or the management of antibiotic-resistant infection. Surgery for the prevention of systemic embolization in patients with large vegetations is an evolving area of clinical practice that will merit continued scrutiny as surgical repair techniques, anesthetic management and perioperative patient outcomes steadily improve in high volume centers. The strength of treatment recommendations is limited by the absence of prospective, randomized controlled trial data, a limitation that applies broadly to the field of valvular heart disease. Ongoing multi-center registry efforts will help fill several important knowledge gaps.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis IV: Nursing Management
Mitral Stenosis III: Medical Management
Myocarditis III: Medical Management
